scholarly journals 46,XX Testicular Disorders of Sex Development With DMD Gene Mutation: First Case Report Identified Prenatally by Integrated Analyses in China

2020 ◽  
Vol 10 ◽  
Author(s):  
Jianlian Deng ◽  
Haoqing Zhang ◽  
Caiyun Li ◽  
Hui Huang ◽  
Saijun Liu ◽  
...  
2015 ◽  
Vol 9 (5) ◽  
pp. 260-268 ◽  
Author(s):  
Ralf Werner ◽  
Isabel M�nig ◽  
Julia August ◽  
Clemens Freiberg ◽  
Ralf L�nstedt ◽  
...  

2021 ◽  
Vol 15 (1) ◽  
Author(s):  
Mercedes Durán ◽  
Iris Faull ◽  
Enrique Lastra ◽  
Jean-Francois Laes ◽  
Ana Belén Rodrigo ◽  
...  

Abstract Background Tumor molecular screening allows categorization of molecular alterations to select the best therapeutic strategy. AT-rich interactive domain-containing 1A (ARID1A) gene mutations are present in gastric, endometrial, and clear cell ovarian tumors. Inactivation of this gene impairs mismatch repair (MMR) machinery leading to an increased mutation burden that correlates with microsatellite instability (MSI), associated with tumor-infiltrating lymphocytes and programmed death ligand 1 (PD-L1) expression. This is the first case report in lung adenocarcinoma of ARID1A gene alterations leading to sporadic MSI, through somatic mutL homolog 1 (MLH1) promoter methylation, with an MLH1 gene mutation as the second somatic hit. Case presentation A 50-year-old never-smoker Bulgarian woman, with no comorbidities and no family history of cancer, was diagnosed with metastatic lung adenocarcinoma. PD-L1 immunohistochemistry (IHC) of tissue biopsies on right groin adenopathies resulted in 30% positivity. Liquid biopsy test reported actionable alterations in ARID1A gene, rearranged during transfection (RET) gene fusions, epidermal growth factor receptor (EGFR) gene R776H mutation, breast cancer (BRCA) genes 1/2, and cyclin-dependent kinase inhibitor 2A (CDKN2A) gene mutations. The patient was treated with immunotherapy, and showed a treatment response lasting for 19 months until a new metastasis appeared at the right deltoid muscle. Genomic analysis of a sample of this metastasis confirmed PD-L1 positivity of greater than 50% with CD8+ T cells expression and showed MSI with a deleterious c.298C>T (p.R100*) MLH1 gene mutation. Multiplex ligation-dependent probe amplification (MLPA) of this sample unveiled MLH1 gene promoter methylation. The MLH1 gene mutation and the MLH1 gene methylation were not present at the germline setting. Conclusions In this particular case, we show that ARID1A gene mutations with sporadic MSI due to somatic MLH1 gene promoter methylation and MLH1 gene mutation could change the prognosis and define the response to immunotherapy in a patient with lung adenocarcinoma. Comprehensive solid and liquid biopsy tests are useful to find out resistance mechanisms to immune checkpoint inhibitors. Our data encourages the development of new therapies against ARID1A mutations and epigenomic methylation when involved in MSI neoplasms.


2017 ◽  
Vol 07 (03) ◽  
Author(s):  
Poaty H ◽  
Ondima I ◽  
Moyen E ◽  
Demba Diop JP ◽  
Moukouma C ◽  
...  

2020 ◽  
Vol 223 ◽  
pp. 106632
Author(s):  
Joanna Nowacka-Woszuk ◽  
Izabela Szczerbal ◽  
Monika Stachowiak ◽  
Stanislaw Dzimira ◽  
Wojciech Nizanski ◽  
...  

2019 ◽  
Author(s):  
Bouchra Bousyf ◽  
Amine Ezzerrouqi ◽  
Youssef Lazreg ◽  
Hanane Latrech

2020 ◽  
Vol 4 (Supplement_1) ◽  
Author(s):  
Yardena Tenenbaum Rakover ◽  
Osnat Admoni ◽  
Ghadir Elias Assad ◽  
Shira London ◽  
Marie Noufi Barhoum ◽  
...  

Abstract Background: Disorders of sex development (DSD) are classified as a congenital discrepancy between external genitalia, gonadal and chromosomal sex. Despite extensive laboratory and imaging investigations, the etiology of DSD is unknown in more than 50% of patients and the diagnosis is often delayed to the second decade of life. Our objective was to evaluate the etiology of DSD by whole-exome sequencing (WES) in children in whom hormonal and candidate gene approaches had not identified the etiology. Methods: Nine patients diagnosed with DSD (eight 46,XY and one 46,XX) were enrolled. Patients underwent hormonal evaluation, including ACTH, GnRH and hCG tests. Candidate genes were sequenced in accordance with the hormonal results. WES was performed for the probands and their parents. Results: The eight 46,XY patients presented with micropenis, cryptorchidism and hypospadias at birth and the 46,XX patient with fusion of the labia majora. In six of the nine patients (66%), a pathogenic mutation was identified by WES that explained the phenotype: four known DSD-causing genes—POR, CHD7, HSD17B3 and WT1—and two novel genes—BMP4 and RFXP2. In three patients, variants of unknown significance were found. An 11-y-old boy had a novel de-novo mutation in BMP4. In humans, mutations in this gene, encoding bone morphogenetic protein 4, are associated with autosomal dominant microphthalmia. BMP4 is expressed in the urethral epithelium and has a role in the development of external genitalia and the pituitary. This is the first report of a BMP4 mutation in a child with DSD. A 12-y-old boy had a mutation in RFXP2, encoding insulin-like 3 hormone receptor, which has been previously reported in adult males with cryptorchidism. This is the first case of an RFXP2 mutation in a child with DSD. Conclusions: WES has a crucial role in early diagnosis of the etiology of DSD, making extensive endocrine testing unnecessary, and has important implications for sex of rearing decisions.


Author(s):  
Mahboobeh Rafigh ◽  
Arash Salmaninejad ◽  
Behzad Sorouri Khorashad ◽  
Azadeh Arabi ◽  
Saman Milanizadeh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document